INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

GW&K Investment Management, LLC's Holding History (CIK: 0001082917)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 141,109 Value ($000) $19 Avg Close — Range —
Q4 2024
Shares 1,387,462 Value ($000) $116 Avg Close — Range —
Q3 2024
Shares 1,394,196 Value ($000) $102 Avg Close — Range —
Q2 2024
Shares 1,393,978 Value ($000) $95 Avg Close — Range —
Q1 2024
Shares 1,598,964 Value ($000) $111 Avg Close — Range —
Q4 2023
Shares 1,628,244 Value ($000) $117 Avg Close — Range —
Q3 2023
Shares 1,692,080 Value ($000) $88 Avg Close — Range —
Q2 2023
Shares 1,727,287 Value ($000) $109 Avg Close — Range —
Q1 2023
Shares 1,753,067 Value ($000) $95 Avg Close — Range —
Q4 2022
Shares 1,450,382 Value ($000) $77 Avg Close — Range —
Q3 2022
Shares 1,465,835 Value ($000) $68,205 Avg Close — Range —
Q2 2022
Shares 583,593 Value ($000) $33,312 Avg Close — Range —
Q1 2022
Shares 549,327 Value ($000) $33,613 Avg Close — Range —
Q4 2021
Shares 373,320 Value ($000) $19,539 Avg Close — Range —